US Stocks
/
Nkarta, Inc. Share Price
Nkarta, Inc. Share Price

Nkarta, Inc. Share Price

NASDAQ: NKTX | Micro Cap
$2.81
-$0.06 (-1.92%) Last updated on 18 Sep, 2026 | 01:29 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Nkarta, Inc. Stock Performance

Open
$2.91
Prev. Close
$2.87
Circuit Range
N/A
Day Range
$2.75 - $2.94
Year Range
$1.71 - $3.71
Volume
35,564
Average Traded
$2.83

Nkarta, Inc. Share Price Today

As of 18 September 2026, Nkarta, Inc.'s share price is $2.81. The stock opened at $2.91, compared to its previous close of $2.87. During today's trading session, Nkarta, Inc.'s share price traded between $2.75 and $2.94, with an average price of $2.84. Over the past 52 weeks, the stock has recorded a high of $3.71 and a low of $1.71. In terms of performance, Nkarta, Inc.'s share price has risen by 33.41% over the last six months and is up 35.34% on a year-on-year basis.

Nkarta, Inc. Share Price Chart

$2.75$2.94
L
Show Current Price
H

Nkarta, Inc. Stock Fundamentals & Key Indicators

Market Cap
$208.29M
PE Ratio (TTM)
-2.00
Dividend Yield
N/A
EPS (TTM)
$-1.41
Revenue (TTM)
N/A
Return On Equity (TTM)
-33.33%
Profit Margin
N/A
Debt to Equity
0.07
Quarterly Earnings Growth YoY
23.39%

Nkarta, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2024Jun 2024Sep 2024Mar 2025Jun 2025Sep 2025
RevenueN/AN/AN/AN/AN/AN/A
Net Profit-$29.52M-$24.99M-$28.34M-$31.98M-$22.98M-$21.71M
Net Profit MarginN/AN/AN/AN/AN/AN/A
Income ChangeN/A15.33%-13.41%-12.84%28.16%5.49%

Nkarta, Inc. Annual Profit & Loss

All figures in USD

Particulars20212022202320242025
RevenueN/AN/AN/AN/AN/A
Net Profit-$86.08M-$113.84M-$117.50M-$108.79M-$104.08M
Net Profit MarginN/AN/AN/AN/AN/A
Income ChangeN/A-32.25%-3.22%7.41%4.33%

About Nkarta, Inc.

Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. The company's lead product candidate is NKX019, a chimeric antigen receptor-natural killer (CAR NK) targeting the CD19 antigen, which is in Phase 1 clinical trial for the treatment of lupus nephritis; systemic sclerosis; idiopathic inflammatory myopathy; and antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis, as well as for systemic lupus erythematosus and myasthenia gravis. It has a research collaboration agreement with CRISPR Therapeutics AG. Nkarta, Inc. was incorporated in 2015 and is based in South San Francisco, California.

Nkarta, Inc. Historical Returns

MonthOpenCloseChange %
Sep 2026
$2.64
$2.81
+2.36%
Aug 2026
$2.10
$2.75
+31.58%
Jul 2026
$2.81
$2.09
-25.75%
Jun 2026
$3.13
$2.81
-12.85%
May 2026
$2.78
$3.23
+16.19%
Apr 2026
$2.14
$2.78
+31.75%
Mar 2026
$2.67
$2.11
-21.71%
Feb 2026
$2.16
$2.69
+21.95%
Jan 2026
$1.85
$2.21
+19.78%
Dec 2025
$1.85
$1.84
-2.38%
Nov 2025
$2.12
$1.89
-10.21%
Oct 2025
$2.13
$2.10
+1.20%

NKTX Share Price FAQs

What is Nkarta, Inc. share price today?

chevron-up
Nkarta, Inc. share price today is $2.81 as on September 18, 2026 at 1:29 am IST.

What is the 52 week high and 52 week low of Nkarta, Inc. stock?

chevron-up
The 52 week high of Nkarta, Inc. stock is $3.71, while the 52 week low is $1.71 as of 18 Sep '26.

What is NKTX's market capitalisation today?

chevron-up
NKTX market capitalisation is $208.29M as of September 18, 2026, at 1:40 pm IST.

What is NKTX's net income for the last quarter?

chevron-up
NKTX's net income for the last quarter is -0.02B USD.

What is the 5 year returns of NKTX?

chevron-up
The 5 year returns of NKTX is -89.88% as on 18 Sep '26.

What is the high & low stock price of NKTX today?

chevron-up
NKTX stock price hit a high of $2.94 and low of $2.75 as of 18 Sep '26.

Can I buy NKTX shares in India?

chevron-up
Yes. You can buy NKTX in India by opening an international trading account.